Hyloris And Hikma Ally On Maxigesic IV In US

Firms Strike Marketing Partnership For Intravenous Paracetamol/Ibuprofen

US Flag Handshake Deal
Hyloris and Hikma have struck a US marketing deal for Maxigesic IV • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business